Lynn Grignard Selected Research

Malaria

3/2022	Prevalence and temporal changes of mutations linked to antimalarial drug resistance in Plasmodium falciparum and Plasmodium vivax in Palawan, Philippines.
1/2021	The Epidemiology of Plasmodium falciparum Malaria in the Bijagos Islands of Guinea-Bissau.
1/2021	G6PD Polymorphisms and Hemolysis After Antimalarial Treatment With Low Single-Dose Primaquine: A Pooled Analysis of Six African Clinical Trials.
5/2020	A novel multiplex qPCR assay for detection of Plasmodium falciparum with histidine-rich protein 2 and 3 (pfhrp2 and pfhrp3) deletions in polyclonal infections.
12/2019	Markers of sulfadoxine-pyrimethamine resistance in Eastern Democratic Republic of Congo; implications for malaria chemoprevention.
8/2018	Low and heterogeneous prevalence of glucose-6-phosphate dehydrogenase deficiency in different settings in Ethiopia using phenotyping and genotyping approaches.
7/2018	Haemolysis and haem oxygenase-1 induction during persistent "asymptomatic" malaria infection in Burkinabé children.
1/2018	Functional antibodies against Plasmodium falciparum sporozoites are associated with a longer time to qPCR-detected infection among schoolchildren in Burkina Faso.
1/2017	G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon.
7/2015	Naturally acquired antibody responses to recombinant Pfs230 and Pfs48/45 transmission blocking vaccine candidates.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lynn Grignard Research Topics

Disease

12	Malaria 03/2022 - 08/2013
10	Infections 12/2022 - 08/2013
6	Hemolysis 01/2021 - 02/2014
5	Glucosephosphate Dehydrogenase Deficiency 01/2021 - 02/2014
2	Persistent Infection 12/2022 - 11/2021
2	Parasitemia 01/2021 - 01/2016
2	Falciparum Malaria (Plasmodium falciparum Malaria) 08/2014 - 02/2014
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Hemolytic Anemia 01/2017
1	Vivax Malaria 01/2017

Drug/Important Bio-Agent (IBA)

7	Primaquine FDA Link 06/2021 - 02/2014
3	Antimalarials (Antimalarial Agents)IBA 03/2022 - 12/2015
3	Proteins (Proteins, Gene)FDA Link 03/2021 - 07/2015
3	EnzymesIBA 07/2018 - 02/2014
3	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2017 - 02/2014
2	AntibodiesIBA 12/2022 - 01/2018
2	Histidine (L-Histidine)FDA Link 03/2021 - 05/2020
2	artemisinin (artemisinine)IBA 01/2021 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2021 - 02/2014
2	Oxidoreductases (Dehydrogenase)IBA 01/2021 - 08/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	glucose-6-phosphate dehydrogenase A-IBA 01/2021
1	InsecticidesIBA 01/2021
1	NucleotidesIBA 01/2021
1	pyrimethamine drug combination fanasil (Fansidar)FDA Link 12/2019
1	Interleukin-10 (Interleukin 10)IBA 07/2018
1	Heme (Haem)IBA 07/2018
1	Malaria VaccinesIBA 01/2018
1	Chloroquine (Aralen)FDA LinkGeneric 01/2017
1	Nucleic AcidsIBA 12/2015
1	Phosphates (Orthophosphate)IBA 08/2015
1	Recombinant ProteinsIBA 07/2015
1	VaccinesIBA 07/2015
1	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 02/2014
1	Merozoite Surface Protein 1 (MSA1)IBA 08/2013
1	DNA (Deoxyribonucleic Acid)IBA 08/2013
1	AntigensIBA 08/2013
1	Immunoglobulin G (IgG)IBA 08/2013

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2016
1	Prenatal Care (Care, Prenatal) 12/2019
1	Chemoprevention 12/2019
1	Blood Transfusion (Blood Transfusions) 01/2017